Genetic Technologies Ltd (NASDAQ:GENE)

4.04
Delayed Data
As of 9:32am ET
 +0.0799 / +2.02%
Today’s Change
1.04
Today|||52-Week Range
11.00
+109.81%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line901.9K-5.5M-9.6M-9.3M
 
 
 
 
 
Depreciation617.3K583.9K407.1K310.7K
 
 
 
 
 
Total Other Cash Flow781.9K-3.0M814.7K330.2K
 
 
 
 
 
Funds From Operations2.3M-8.0M-8.3M-9.0M
 
 
 
 
 
Funds From/For Other Operating Expenses66.4K5.2K-651.4K1.4M
 
 
 
 
 
Net Cash Flow - Operating Activities2.2M-8.0M-7.7M-10.4M
 
 
 
 
 
 
InvestingIncrease In Investments0.000.000.00-104.8K
 
 
Decrease In Investments0.00558.1K48.0K530.1K
 
 
 
 
Capital Expenditures-139.8K-79.3K-54.8K-44.0K
 
 
 
 
 
Fixed Asset Disposal144.8K32.7K1.2K0.00
 
 
 
 
Net Assets From Acquisitions 0.00-10.390.00-149.2K
 
 
 
Other Investing - Uses0.000.00-177.0K-18.8K
 
 
 
Net Cash Flow Investing5.0K511.5K-182.6K213.3K
 
 
 
 
 
 
FinancingShort Term Borrowings0.00-869.780.000.00
 
 
Long Term Borrowings0.000.000.005.1M
 
 
Long Term Debt Reduction-315.0K-52.1K-18.1K0.00
 
 
 
 
Net Proceeds Stock Sale0.0011.3M465.8K5.8M
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing-315.0K11.3M447.7K10.9M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-125.3K131.4K80.3K-53.7K
 
 
 
 
 
 
Net Change In Cash1.9M3.8M-7.4M750.7K
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account